Carvedilol Tablet, Film Coated
Product Images NDC 65862-144

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 65862-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Fig1)

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Fig2)

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig3)

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig4)

FDA Label Image

Package Label-principal Display Panel (3.125 mg (100 Tablet Bottle))

Package Label-principal Display Panel (3.125 mg (100 Tablet Bottle))
This is a description of Carvedilol tablets, USP, distributed by Aurobindo Pharma. The dosages and other important information are printed on the label. The text includes a warning to store the medication correctly and to follow the instructions provided by the supplier to prevent adverse effects. There is also a small section regarding printing on the packaging.*
FDA Label Image

Package Label-principal Display Panel (6.25 mg (100 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (12.5 mg (100 Tablet Bottle))

Package Label-principal Display Panel (12.5 mg (100 Tablet Bottle))
This is a drug description for Esch fim-cuald tablets containing Carvedilol USP 12.5 mg manufactured by Aurobindo Pharma USA, Inc. It is dispensed in a light-resistant container and comes in a pack of 100 tablets. It is important to protect the tablets from moisture and use safety closures when dispensing. There is also a printing zone coding area included in the packaging.*
FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablet Bottle))

Package Label-principal Display Panel (25 mg (100 Tablet Bottle))
This text provides information about the prescription medicine Carvedilol, sold by Aurobindo Pharma. Each film-coated tablet contains USP 25 mg of Carvedilol. The text recommends reading the accompanying prescribing information for usual dosage. The medicine should be dispensed in a light-resistant container and stored between 20°C to 25°C. Aurobindo Pharma is located in East Windsor, NJ, and the product is made in India. It also includes a code and a warning about using safety closures when dispensing the product, unless otherwise directed by a physician or requested by the purchaser.*
FDA Label Image

Chemical Structure (Carvedilol Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.